INCY vs TVRD · P/E 14, rev $5.14B vs rev $2.6M
Incyte Corporation (INCY) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. TVRD currently screens at market cap $0.
Not investment advice. Open the INCY and TVRD stock pages for the full models.
Not investment advice.